February 4th this year marked World Cancer day. Daily, we see fund raisers for Marie Curie / Breast Cancer Now / Cancer Research UK and many others on the street working hard to raise money for their charity. There might be one of your fellow work colleagues running the London Marathon for a cancer charity or you may have been impacted by cancer yourself in one form or another. The positive and reassuring thing is how hard our pharmaceutical professionals are working to develop new and innovative drugs to battle cancer each year.
Cancer Research UK stated that "1 in 2 people born after 1960 in the UK will be diagnosed with some form of cancer in their lifetime but, with the life changing advances in research over the last 40 years, survival has doubled."
Jacintha has struck a really nice chord with her blog here, it's incredible to see how much life saving treatments have developed in such a short space of time. Here's to another 40 years of progress and fighting cancer.
Only six years ago, research and development in anti-cancer drugs accounted for just under a fifth of all R&D expenditure by pharmaceutical companies. By 2014, investment in these treatments accounted for nearly a third. This reflects a recognition of the growing importance of research into cancer care and a commitment by the pharmaceutical industry, alongside charities and academia, to discover more, and better, treatments. This commitment isn't just a pipe dream - we are seeing those efforts in investment bearing fruit now. In 2015, the European Medicines Agency approved 14 new and innovative cancer medicines. Knowing that we are working hard to contribute to advancing medicine in this area makes me, as pharmaceutical physician extremely proud.